Tamoxifen may increase risk of uterine sarcoma.
Gottlieb
Scott
S
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D004348:Drug Labeling; D005260:Female; D006801:Humans; D012509:Sarcoma / Q000139:chemically induced*; D013629:Tamoxifen / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000139:chemically induced*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen